Literature DB >> 16608048

Diabetic peripheral neuropathic pain: clinical and quality-of-life issues.

Charles E Argoff1, B Eliot Cole, David A Fishbain, Gordon A Irving.   

Abstract

Diabetic peripheral neuropathy (DPN) is estimated to be present in 50% of people living with diabetes mellitus (DM). Comorbidities of DM, such as macrovascular and microvascular changes, also Interact with DPN and affect its course. In patients with DM, DPN Is the leading cause of foot ulcers, which in turn are a major cause of amputation in the United States. Although most patients with DPN do not have pain, approximately 11% of patients with DPN have chronic, painful symptoms that diminish quality of life, disrupt sleep, and can lead to depression. Despite the number of patients affected by DPN pain, little consensus exists about the pathophysiology, best diagnostic tools, and primary treatment choices. This article reviews the current knowledge about and presents recommendations for diagnostic assessment of DPN pain based on a review of the literature.

Entities:  

Mesh:

Year:  2006        PMID: 16608048     DOI: 10.1016/s0025-6196(11)61474-2

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  53 in total

Review 1.  Diabetic Polyneuropathy - Advances in Diagnosis and Intervention Strategies.

Authors:  Solomon Tesfaye; Gordon Sloan
Journal:  Eur Endocrinol       Date:  2020-04-17

2.  The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.

Authors:  Jenny L Wilkerson; Erin D Milligan
Journal:  ISRN Anesthesiol       Date:  2011

Review 3.  Early diabetic neuropathy: triggers and mechanisms.

Authors:  Maxim Dobretsov; Dmitry Romanovsky; Joseph R Stimers
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

4.  Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure.

Authors:  Meryl Brod; Steven I Blum; Donald M Bushnell; Abhilasha Ramasamy
Journal:  Qual Life Res       Date:  2015-06-12       Impact factor: 4.147

5.  Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001-2004 NHANES.

Authors:  L H Soderstrom; S P Johnson; V A Diaz; A G Mainous
Journal:  Diabet Med       Date:  2012-01       Impact factor: 4.359

6.  Exercise-induced modulation of pain in adults with and without painful diabetic neuropathy.

Authors:  Matthew T Knauf; Kelli F Koltyn
Journal:  J Pain       Date:  2014-03-13       Impact factor: 5.820

7.  An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic subjects.

Authors:  Azam Alamdari; Rambod Mozafari; Abbas Tafakhori; Sara Faghihi-Kashani; Nima Hafezi-Nejad; Sara Sheikhbahaei; Neda Naderi; Maryam Ebadi; Alireza Esteghamati
Journal:  Neurol Sci       Date:  2015-04-08       Impact factor: 3.307

8.  Clinical Approach to the Treatment of Painful Diabetic Neuropathy.

Authors:  Alexandra Hovaguimian; Christopher H Gibbons
Journal:  Ther Adv Endocrinol Metab       Date:  2011-02       Impact factor: 3.565

9.  Opioid utilization patterns among medicare patients with diabetic peripheral neuropathy.

Authors:  Jacqueline Pesa; Roxanne Meyer; Tiffany P Quock; Stacy K Rattana; Samir H Mody
Journal:  Am Health Drug Benefits       Date:  2013-05

10.  Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in diabetic neuropathic pain.

Authors:  Franco Cauda; Katiuscia Sacco; Federico D'Agata; Sergio Duca; Dario Cocito; Giuliano Geminiani; Filippo Migliorati; Gianluca Isoardo
Journal:  BMC Neurosci       Date:  2009-11-26       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.